Reports about it "Rostec".

“The vaccine complies with all WHO recommendations and global pharmaceutical trends, it is the first Russian drug of this composition for the prevention of influenza. When creating this vaccine, no preservatives, adjuvants and immunomodulators are used, ”said Sergey Chemezov, general director of the Rostec state corporation.

The development of this vaccine began in 2017. It is planned that Ultrix Quadri in the future will be able to replace the preparations of the previous generation. The use of this vaccine is indicated for people from 18 years.

Earlier, progorod43.ru reported that in the Kirov region they will produce the first Russian domestic polio vaccine for adults.